Use of a CD28 binding substance for making a pharmaceutical composition
- 专利权人:
- Thomas Hunig
- 发明人:
- Thomas Hunig
- 申请号：
- US12251039
- 公开号：
- US08389016B2
- 申请日:
- 2008.10.14
- 申请国别(地区):
- US
- 年份:
- 2013
- 代理人:
- 摘要：
- The invention relates to the use of a CD28-specific superagonistic monoclonal antibody (mAb) or of a mimicry compound hereto for making a pharmaceutical composition for the induction and/or multiplication of regulatory T cells.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF A CD28 BINDING SUBSTANCE FOR MAKING A PHARMACEUTICAL COMPOSITION
- USE OF AN ACTIVE SUBSTANCE BINDING TO CD28 FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF B-CLL
- CONSTRUCT, GENETICALLY MODIFIED LYMPHOCYTE, PREPARATION METHOD AND USAGE THEREOF
- RECEPTEUR DE LYMPHOCYTES T DE HAUTE STABILITE ET SON PROCEDE DE PREPARATION ET SON APPLICATION
- USE OF CD28-SPECIFIC MONOCLONAL ANTIBODIES FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR TREATING VIRUS INFECTIONS
